Literature DB >> 20011207

Management of locally advanced primary and recurrent rectal cancer.

Johannes H W de Wilt1, Maarten Vermaas, Floris T J Ferenschild, Cornelis Verhoef.   

Abstract

Treatment for patients with locally advanced and recurrent rectal cancer differs significantly from patients with rectal cancer restricted to the mesorectum. Adequate preoperative imaging of the pelvis is therefore important to identify those patients who are candidates for multimodality treatment, including preoperative chemoradiation protocols, intraoperative radiotherapy, and extended surgical resections. Much effort should be made to select patients with these advanced tumors for treatment in specialized referral centers. This has been shown to reduce morbidity and mortality and improve long-term survival rates. In this article, we review the best treatment options for patients with locally advanced and recurrent rectal cancer. We also emphasize the necessity of a multidisciplinary team, including a radiologist, radiation oncologist, urologist, surgical oncologist, plastic surgeon, and gynecologist in the diagnosis and treatment of patients with these pelvic tumors.

Entities:  

Keywords:  Primary locally advanced rectal cancer; radiotherapy; recurrent rectal cancer; surgery

Year:  2007        PMID: 20011207      PMCID: PMC2789507          DOI: 10.1055/s-2007-984870

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  115 in total

1.  Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93; 872-878).

Authors:  C Verhoef; J J Nuytens; A S T Planting; J H W de Wilt
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

Review 2.  Surgery for recurrent rectal carcinoma: The role of preoperative magnetic resonance imaging.

Authors:  C Messiou; A Chalmers; K Boyle; P Sagar
Journal:  Clin Radiol       Date:  2006-03       Impact factor: 2.350

3.  Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour.

Authors:  C L H Chan; E L Bokey; P H Chapuis; A A Renwick; O F Dent
Journal:  Br J Surg       Date:  2006-01       Impact factor: 6.939

4.  Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis.

Authors:  Yoshihiro Moriya; Takayuki Akasu; Shin Fujita; Seiichirou Yamamoto
Journal:  Dis Colon Rectum       Date:  2004-12       Impact factor: 4.585

5.  Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.

Authors:  M Ueno; M Oya; K Azekura; T Yamaguchi; T Muto
Journal:  Br J Surg       Date:  2005-06       Impact factor: 6.939

6.  High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.

Authors:  K M Alektiar; M J Zelefsky; P B Paty; J Guillem; L B Saltz; A M Cohen; B D Minsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

7.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

8.  Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma.

Authors:  G H Mannaerts; H Martijn; M A Crommelin; G N Stultiëns; W Dries; O J van Driel; H J Rutten
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

9.  Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer.

Authors:  K Suzuki; L L Gunderson; R M Devine; A L Weaver; R R Dozois; D M Ilstrup; J A Martenson; M J O'Connell
Journal:  Cancer       Date:  1995-02-15       Impact factor: 6.860

10.  Pelvic recurrence of rectal cancer. Options for curative resection.

Authors:  H J Wanebo; D L Gaker; R Whitehill; R F Morgan; W C Constable
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

View more
  13 in total

Review 1.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

Review 2.  Surgery for Locally Advanced T4 Rectal Cancer: Strategies and Techniques.

Authors:  Ramzi M Helewa; Jason Park
Journal:  Clin Colon Rectal Surg       Date:  2016-06

3.  Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm phase I-II study.

Authors:  Engy M Aboelnaga; Mohamed A Daoud; Entesar I Eladl; Amir M Zaid
Journal:  Med Oncol       Date:  2015-03-07       Impact factor: 3.064

4.  Lateral pelvic lymphadenectomy for low rectal cancer: a META-analysis of recurrence rates.

Authors:  M R Fahy; M E Kelly; T Nugent; E Hannan; D C Winter
Journal:  Int J Colorectal Dis       Date:  2020-11-26       Impact factor: 2.571

5.  Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer.

Authors:  R S Turley; B G Czito; J C Haney; D S Tyler; C R Mantyh; J Migaly
Journal:  Tech Coloproctol       Date:  2012-09-18       Impact factor: 3.781

6.  Multivisceral resections for rectal cancers: short-term oncological and clinical outcomes from a tertiary-care center in India.

Authors:  Vishwas D Pai; Sudhir Jatal; Vikas Ostwal; Reena Engineer; Supreeta Arya; Prachi Patil; Munita Bal; Avanish P Saklani
Journal:  J Gastrointest Oncol       Date:  2016-06

7.  Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.

Authors:  A M Mehta; G Hellawell; D Burling; S Littler; A Antoniou; J T Jenkins
Journal:  Tech Coloproctol       Date:  2018-10-10       Impact factor: 3.781

8.  Clinical outcome of patients with complete pathological response to neoadjuvant chemoradiotherapy for locally advanced rectal cancers: the Indian scenario.

Authors:  Snita Sinukumar; Prachi Patil; Reena Engineer; Ashwin Desouza; Avanish Saklani
Journal:  Gastroenterol Res Pract       Date:  2014-12-28       Impact factor: 2.260

9.  MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.

Authors:  Vetri Sudar Jayaprakasam; Viktoriya Paroder; Peter Gibbs; Raazi Bajwa; Natalie Gangai; Ramon E Sosa; Iva Petkovska; Jennifer S Golia Pernicka; James Louis Fuqua; David D B Bates; Martin R Weiser; Andrea Cercek; Marc J Gollub
Journal:  Eur Radiol       Date:  2021-07-29       Impact factor: 7.034

10.  Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer.

Authors:  M Sokolov; K Angelov; M Vasileva; M P Atanasova; A Vlahova; G Todorov
Journal:  Onco Targets Ther       Date:  2015-09-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.